Achieving High‐Quality Multicultural Geriatric Care

,

doi:10.1111/jgs.13924

Cited by 18 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They were teaching them English, and they were teaching them about dementia." 176 Cultural competency in health-care settings has been shown to improve health outcomes for people with dementia.177 While geriatric and dementia-focused training across interdisciplinary teams should be ubiquitous, training for cultural sensitivity will require regional specificity, based on the racial, ethnic, and cultural characteristics of each community. Unique risks and challenges of dementia for the intellectual and developmental disability community should be respected in the same way.…”

Section: Action Item #17mentioning

confidence: 99%

The Role of Philanthropy in Alzheimer’s Disease Therapeutic Development

Altimus¹

2022

Alzheimer's Disease Drug Development

View full text Add to dashboard Cite

The Milken Institute is a nonprofit, nonpartisan think tank.For the past three decades, the Milken Institute has served as a catalyst for practical, scalable solutions to global challenges by connecting human, financial, and educational resources to those who need them. Guided by a conviction that the best ideas, underresourced, cannot succeed, we conduct research and analysis and convene top experts, innovators, and influencers from different backgrounds and competing viewpoints. We leverage this expertise and insight to construct programs and policy initiatives.These activities are designed to help people build meaningful lives, in which they can experience health and well-being, pursue effective education and gainful employment, and access the resources required to create ever-expanding opportunities for themselves and their broader communities. ABOUT THE CENTER FOR THE FUTURE OF AGINGThe Milken Institute Center for the Future of Aging is nonpartisan, independent, collaborative, and solutions-focused. The Center promotes healthy, productive, and purposeful aging to improve lives and strengthen societies. Through its Healthy Longevity program, the Center for the Future of Aging seeks to increase awareness of developing knowledge, evidence-based programs, and strategies to promote prevention and wellness for longer, healthier lives. Recognizing the growing prevalence of Alzheimer's disease and related dementias, the Center seeks to develop and promote optimal strategies to maintain and improve brain health for all ages, genders, and across diverse populations. The Center also works to find innovative solutions to finance long-term care support services and keep people independent and healthy as long as possible.

show abstract

Section: Action Item #17mentioning

confidence: 99%

The Role of Philanthropy in Alzheimer’s Disease Therapeutic Development

Altimus¹

2022

Alzheimer's Disease Drug Development

View full text Add to dashboard Cite

show abstract

2021 Alzheimer's disease facts and figures

2021

Alzheimer's & Dementia

1,771

849

View full text Add to dashboard Cite

This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality and morbidity, use and costs of care, and the overall impact on caregivers and society. The Special Report discusses the challenges of providing equitable health care for people with dementia in the United States. An estimated 6.2 million Americans age 65 and older are living with Alzheimer's dementia today. This number could grow to 13.8 million by 2060 barring the development of medical breakthroughs to prevent, slow or cure AD. Official death certificates recorded 121,499 deaths from AD in 2019, the latest year for which data are available, making Alzheimer's the sixth‐leading cause of death in the United States and the fifth‐leading cause of death among Americans age 65 and older. Between 2000 and 2019, deaths from stroke, heart disease and HIV decreased, whereas reported deaths from AD increased more than 145%. This trajectory of deaths from AD was likely exacerbated in 2020 by the COVID‐19 pandemic. More than 11 million family members and other unpaid caregivers provided an estimated 15.3 billion hours of care to people with Alzheimer's or other dementias in 2020. These figures reflect a decline in the number of caregivers compared with a decade earlier, as well as an increase in the amount of care provided by each remaining caregiver. Unpaid dementia caregiving was valued at $256.7 billion in 2020. Its costs, however, extend to family caregivers’ increased risk for emotional distress and negative mental and physical health outcomes — costs that have been aggravated by COVID‐19. Average per‐person Medicare payments for services to beneficiaries age 65 and older with AD or other dementias are more than three times as great as payments for beneficiaries without these conditions, and Medicaid payments are more than 23 times as great. Total payments in 2021 for health care, long‐term care and hospice services for people age 65 and older with dementia are estimated to be $355 billion. Despite years of efforts to make health care more equitable in the United States, racial and ethnic disparities remain — both in terms of health disparities, which involve differences in the burden of illness, and health care disparities, which involve differences in the ability to use health care services. Blacks, Hispanics, Asian Americans and Native Americans continue to have a higher burden of illness and lower access to health care compared with Whites. Such disparities, which have become more apparent during COVID‐19, extend to dementia care. Surveys commissioned by the Alzheimer's Association recently shed new light on the role of discrimination in dementia care, the varying levels of trust between racial and ethnic groups in medical research, and the differences between groups in their levels of concern about and awareness of Alzheimer's disease. These findings emphasize the need to increase racial and ethnic diversity in both the dementia care workforce and in Alzheimer's clinical trials.

show abstract

Ethnogeriatrics

Mariano

Carrol

2023

Geriatric Medicine

View full text Add to dashboard Cite

Achieving High‐Quality Multicultural Geriatric Care

Cited by 18 publications

References 28 publications

The Role of Philanthropy in Alzheimer’s Disease Therapeutic Development

The Role of Philanthropy in Alzheimer’s Disease Therapeutic Development

2021 Alzheimer's disease facts and figures

Ethnogeriatrics

Contact Info

Product

Resources

About